Skip to main content
Erschienen in: International Journal of Legal Medicine 5/2007

01.09.2007 | Original Article

Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992–2003

verfasst von: Gudrun Høiseth, Jørgen G. Bramness, Asbjørg S. Christophersen, Jørg Mørland

Erschienen in: International Journal of Legal Medicine | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Carisoprodol is commonly prescribed as a centrally acting muscle relaxant, but it is also subject to abuse. The literature describing fatal intoxications with the drug is limited to a relatively small number of cases, and there are inconsistencies with regard to which concentration levels that are toxic. We therefore investigated all forensic autopsies at the Norwegian Institute of Public Health during the period 1992–2003 where carisoprodol was detected. The median concentrations of carisoprodol in intoxication with carisoprodol only or with only minor other analytical findings was 36 mg/l (range 8–65 mg/l; n=5). In the rest of the intoxications, the relevance of carisoprodol relative to the other drugs detected was variable (n=93). When the number of intoxications with carisoprodol each year were divided by the number of defined daily doses (DDD) sold, a fatal toxicity index between 5.6 and 6.9 deaths/1 million DDD was obtained. The total number of cases where carisoprodol was detected increased during the period studied, which correlated to sales figures for the drug. We conclude that carisoprodol can be fatal in concentrations below those indicated in some of the previously published literature. There were, however, only a small number of cases where the cause of death can be attributed to use of carisoprodol alone.
Literatur
1.
Zurück zum Zitat Dalen P, Alvan G, Wakelkamp M, Olsen H (1996) Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 6:387–394PubMedCrossRef Dalen P, Alvan G, Wakelkamp M, Olsen H (1996) Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 6:387–394PubMedCrossRef
2.
Zurück zum Zitat van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM (2003) Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine 28:1978–1992PubMedCrossRef van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM (2003) Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine 28:1978–1992PubMedCrossRef
3.
Zurück zum Zitat Hindle TH III (1972) Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med 117:7–11PubMed Hindle TH III (1972) Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med 117:7–11PubMed
4.
Zurück zum Zitat Boyles W, Glassmann J, Soyka J (1983) Management of acute muskuloskeletal conditions: thoracolumbar strain and pain. A double-blind evaluation comparing the efficacy and safety of carisoprodol with diazepam. Today’s Ther Trends 1:1–16 Boyles W, Glassmann J, Soyka J (1983) Management of acute muskuloskeletal conditions: thoracolumbar strain and pain. A double-blind evaluation comparing the efficacy and safety of carisoprodol with diazepam. Today’s Ther Trends 1:1–16
5.
Zurück zum Zitat Rollings H, Glassmann J, Soyka J (1982) Management of acute muskuloskeletal conditions—thoracolumbar strain and sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzadrine hydrochloride. Curr Ther Res 34:917–928 Rollings H, Glassmann J, Soyka J (1982) Management of acute muskuloskeletal conditions—thoracolumbar strain and sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzadrine hydrochloride. Curr Ther Res 34:917–928
6.
Zurück zum Zitat Boothby L, Doering P, Hatton R (2003) Carisoprodol: a marginally effective skeletal muscle relaxant with serious abuse potential. Hosp Pharm 38:337–345 Boothby L, Doering P, Hatton R (2003) Carisoprodol: a marginally effective skeletal muscle relaxant with serious abuse potential. Hosp Pharm 38:337–345
7.
Zurück zum Zitat Wyller TB, Korsmo G, Gadeholt G (1991) Dependence on carisoprodol (Somadril)? A prospective withdrawal study among prisoners [Avhengig av karisoprodol (Somadril)? En prospektiv seponeringsundersøkelse blant fengselsinnsatte]. Tidsskr Nor Laegeforen 111:193–195PubMed Wyller TB, Korsmo G, Gadeholt G (1991) Dependence on carisoprodol (Somadril)? A prospective withdrawal study among prisoners [Avhengig av karisoprodol (Somadril)? En prospektiv seponeringsundersøkelse blant fengselsinnsatte]. Tidsskr Nor Laegeforen 111:193–195PubMed
8.
Zurück zum Zitat Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM (1999) Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis 18:51–56PubMedCrossRef Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM (1999) Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis 18:51–56PubMedCrossRef
9.
Zurück zum Zitat Bailey DN, Briggs JR (2002) Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 117:396–400PubMedCrossRef Bailey DN, Briggs JR (2002) Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 117:396–400PubMedCrossRef
10.
Zurück zum Zitat Sikdar S, Basu D, Malhotra AK, Varma VK, Mattoo SK (1993) Carisoprodol abuse: a report from India. Acta Psychiatr Scand 88:302–303PubMed Sikdar S, Basu D, Malhotra AK, Varma VK, Mattoo SK (1993) Carisoprodol abuse: a report from India. Acta Psychiatr Scand 88:302–303PubMed
11.
Zurück zum Zitat Bramness JG, Morland J, Sorlid HK, Rudberg N, Jacobsen D (2005) Carisoprodol intoxications and serotonergic features. Clin Toxicol 43:39–45 Bramness JG, Morland J, Sorlid HK, Rudberg N, Jacobsen D (2005) Carisoprodol intoxications and serotonergic features. Clin Toxicol 43:39–45
12.
Zurück zum Zitat Siddiqi M, Jennings CA (2004) A near-fatal overdose of carisoprodol (SOMA): case report. J Toxicol Clin Toxicol 42:239–240PubMedCrossRef Siddiqi M, Jennings CA (2004) A near-fatal overdose of carisoprodol (SOMA): case report. J Toxicol Clin Toxicol 42:239–240PubMedCrossRef
13.
Zurück zum Zitat Roth BA, Vinson DR, Kim S (1998) Carisoprodol-induced myoclonic encephalopathy. J Toxicol Clin Toxicol 36:609–612PubMedCrossRef Roth BA, Vinson DR, Kim S (1998) Carisoprodol-induced myoclonic encephalopathy. J Toxicol Clin Toxicol 36:609–612PubMedCrossRef
14.
Zurück zum Zitat Roberge RJ, Lin E, Krenzelok EP (2000) Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 18:61–64PubMedCrossRef Roberge RJ, Lin E, Krenzelok EP (2000) Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 18:61–64PubMedCrossRef
15.
Zurück zum Zitat Roache JD, Griffiths RR (1987) Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 243:978–988PubMed Roache JD, Griffiths RR (1987) Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 243:978–988PubMed
16.
Zurück zum Zitat Winek CL, Wahba WW, Winek CL Jr, Balzer TW (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122:107–123PubMedCrossRef Winek CL, Wahba WW, Winek CL Jr, Balzer TW (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122:107–123PubMedCrossRef
17.
Zurück zum Zitat Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 42:79–87PubMed Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 42:79–87PubMed
18.
Zurück zum Zitat Chung H, Park M, Hahn E, Choi H, Choi H, Lim M (2004) Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci 1025:458–464PubMedCrossRef Chung H, Park M, Hahn E, Choi H, Choi H, Lim M (2004) Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci 1025:458–464PubMedCrossRef
19.
Zurück zum Zitat Backer RC, Zumwalt R, McFeeley P, Veasey S, Wohlenberg N (1990) Carisoprodol concentrations from different anatomical sites: three overdose cases. J Anal Toxicol 14:332–334PubMed Backer RC, Zumwalt R, McFeeley P, Veasey S, Wohlenberg N (1990) Carisoprodol concentrations from different anatomical sites: three overdose cases. J Anal Toxicol 14:332–334PubMed
20.
Zurück zum Zitat Adams HR, Kerzee T, Morehead CD (1975) Carisoprodol-related death in a child. J Forensic Sci 20:200–202PubMed Adams HR, Kerzee T, Morehead CD (1975) Carisoprodol-related death in a child. J Forensic Sci 20:200–202PubMed
21.
Zurück zum Zitat Davis GG, Alexander CB (1998) A review of carisoprodol deaths in Jefferson County, Alabama. South Med J 91:726–730PubMed Davis GG, Alexander CB (1998) A review of carisoprodol deaths in Jefferson County, Alabama. South Med J 91:726–730PubMed
22.
Zurück zum Zitat Ronning M (2001) Drug consumption in Norway 1996–2000 [Legemiddelforbruket i Norge 1996–2000], Norwegian Medicinal Depot, Oslo Ronning M (2001) Drug consumption in Norway 1996–2000 [Legemiddelforbruket i Norge 1996–2000], Norwegian Medicinal Depot, Oslo
23.
Zurück zum Zitat Ronning M, Sanner T, Boe GH, Litleskare I, Strøm H, Granum T (2005) Drug consumption in Norway 2000–2004 [Legemiddelforbruket i Norge 2000–2004], Norwegian Institute of Public Health, Oslo Ronning M, Sanner T, Boe GH, Litleskare I, Strøm H, Granum T (2005) Drug consumption in Norway 2000–2004 [Legemiddelforbruket i Norge 2000–2004], Norwegian Institute of Public Health, Oslo
24.
Zurück zum Zitat Oydvin K, Ronning M, Sakshaug S, Blix H, Ullerud T (1997) Drug consumption in Norway 1992–1996 [Legemiddelforbruket i Norge 1992–1996], Norsk Medisinaldepot AS, Oslo Oydvin K, Ronning M, Sakshaug S, Blix H, Ullerud T (1997) Drug consumption in Norway 1992–1996 [Legemiddelforbruket i Norge 1992–1996], Norsk Medisinaldepot AS, Oslo
27.
Zurück zum Zitat Reith DM, Fountain J, McDowell R, Tilyard M (2003) Comparison of the fatal toxicity index of zopiclone with benzodiazepines. J Toxicol Clin Toxicol 41:975–980PubMedCrossRef Reith DM, Fountain J, McDowell R, Tilyard M (2003) Comparison of the fatal toxicity index of zopiclone with benzodiazepines. J Toxicol Clin Toxicol 41:975–980PubMedCrossRef
28.
Zurück zum Zitat Hilberg T, Rogde S, Morland J (1999) Postmortem drug redistribution—human cases related to results in experimental animals. J Forensic Sci 44:3–9PubMed Hilberg T, Rogde S, Morland J (1999) Postmortem drug redistribution—human cases related to results in experimental animals. J Forensic Sci 44:3–9PubMed
29.
Zurück zum Zitat Hilberg T, Morland J, Bjorneboe A (1994) Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int 64:47–55PubMedCrossRef Hilberg T, Morland J, Bjorneboe A (1994) Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int 64:47–55PubMedCrossRef
30.
Zurück zum Zitat Pelissier-Alicot AL, Gaulier JM, Dupuis C et al (2006) Post-mortem redistribution of three beta-blockers in the rabbit. Int J Legal Med 120:226–232PubMedCrossRef Pelissier-Alicot AL, Gaulier JM, Dupuis C et al (2006) Post-mortem redistribution of three beta-blockers in the rabbit. Int J Legal Med 120:226–232PubMedCrossRef
31.
Zurück zum Zitat Schulz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52:895–911PubMed Schulz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52:895–911PubMed
32.
Zurück zum Zitat Olsen H, Koppang E, Alvan G, Morland J (1994) Carisoprodol elimination in humans. Ther Drug Monit 16:337–340PubMedCrossRef Olsen H, Koppang E, Alvan G, Morland J (1994) Carisoprodol elimination in humans. Ther Drug Monit 16:337–340PubMedCrossRef
33.
Zurück zum Zitat Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Morland J (2005) The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects. Eur J Clin Pharmacol 61:499–506PubMedCrossRef Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Morland J (2005) The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects. Eur J Clin Pharmacol 61:499–506PubMedCrossRef
34.
Zurück zum Zitat Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151–347PubMed Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151–347PubMed
35.
Zurück zum Zitat Steentoft A, Teige B, Ceder G et al (2001) Fatal poisoning in drug addicts in the Nordic countries. Forensic Sci Int 123:63–69PubMedCrossRef Steentoft A, Teige B, Ceder G et al (2001) Fatal poisoning in drug addicts in the Nordic countries. Forensic Sci Int 123:63–69PubMedCrossRef
36.
Zurück zum Zitat Jonsson A, Holmgren P, Ahlner J (2004) Fatal intoxications in a Swedish forensic autopsy material during 1992–2002. Forensic Sci Int 143:53–59PubMedCrossRef Jonsson A, Holmgren P, Ahlner J (2004) Fatal intoxications in a Swedish forensic autopsy material during 1992–2002. Forensic Sci Int 143:53–59PubMedCrossRef
37.
Zurück zum Zitat Morland J (2000) Driving under the influence of medication and various substances other than alcohol [Kjøring under påvirkning av medikamenter og andre rusmidler enn alkohol]. Tidsskr Nor Laegeforen 120:2148–2150PubMed Morland J (2000) Driving under the influence of medication and various substances other than alcohol [Kjøring under påvirkning av medikamenter og andre rusmidler enn alkohol]. Tidsskr Nor Laegeforen 120:2148–2150PubMed
38.
Zurück zum Zitat Meel BL (2004) Incidence and patterns of violent and/or traumatic deaths between 1993 and 1999 in the Transkei region of South Africa. J Trauma 57:125–129PubMedCrossRef Meel BL (2004) Incidence and patterns of violent and/or traumatic deaths between 1993 and 1999 in the Transkei region of South Africa. J Trauma 57:125–129PubMedCrossRef
39.
Zurück zum Zitat Qin P, Agerbo E, Westergard-Nielsen N, Eriksson T, Mortensen PB (2000) Gender differences in risk factors for suicide in Denmark. Br J Psychiatry 177:546–550PubMedCrossRef Qin P, Agerbo E, Westergard-Nielsen N, Eriksson T, Mortensen PB (2000) Gender differences in risk factors for suicide in Denmark. Br J Psychiatry 177:546–550PubMedCrossRef
40.
Zurück zum Zitat Demetriades D, Gkiokas G, Velmahos GC, Brown C, Murray J, Noguchi T (2004) Alcohol and illicit drugs in traumatic deaths: prevalence and association with type and severity of injuries. J Am Coll Surg 199:687–692PubMedCrossRef Demetriades D, Gkiokas G, Velmahos GC, Brown C, Murray J, Noguchi T (2004) Alcohol and illicit drugs in traumatic deaths: prevalence and association with type and severity of injuries. J Am Coll Surg 199:687–692PubMedCrossRef
41.
Zurück zum Zitat Bramness JG, Skurtveit S, Grung M, Morland J (2000) Centrally acting muscle relaxants and traffic hazards [Sentralt virkende muskelrelakserende midler i trafikken]. Tidsskr Nor Laegeforen 120:1966–1969PubMed Bramness JG, Skurtveit S, Grung M, Morland J (2000) Centrally acting muscle relaxants and traffic hazards [Sentralt virkende muskelrelakserende midler i trafikken]. Tidsskr Nor Laegeforen 120:1966–1969PubMed
42.
Zurück zum Zitat Substance Abuse and Mental Health Service Administration (2003) Emergency department trends from the drug abuse warning network, final estimates 1995–2002. DAWN Series D-24, Rockville, MD Substance Abuse and Mental Health Service Administration (2003) Emergency department trends from the drug abuse warning network, final estimates 1995–2002. DAWN Series D-24, Rockville, MD
43.
Zurück zum Zitat Koski A, Vuori E, Ojanpera I (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med 119:344–348PubMedCrossRef Koski A, Vuori E, Ojanpera I (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med 119:344–348PubMedCrossRef
Metadaten
Titel
Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992–2003
verfasst von
Gudrun Høiseth
Jørgen G. Bramness
Asbjørg S. Christophersen
Jørg Mørland
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
International Journal of Legal Medicine / Ausgabe 5/2007
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-006-0139-1

Weitere Artikel der Ausgabe 5/2007

International Journal of Legal Medicine 5/2007 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …